Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M270Revenue (TTM) $M11.0Net Margin (%)-1,018.2Altman Z-Score-5.0
Enterprise Value $M189EPS (TTM) $-2.9Operating Margin %-1,002.5Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.3Pre-tax Margin (%)-1,018.2Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %-15.2Quick Ratio4.5Cash flow > EarningsY
Price/Sales21.25-y EBITDA Growth Rate %-4.8Current Ratio4.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-68.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-81.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M44.6ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with DVAX

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

DVAX is held by these investors:

DVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Janssen RobertVice President 2017-01-24Buy6,000$4.0449.75view
Janssen RobertVice President 2016-06-28Buy1,452$13.68-55.77view
Gray EddieCEO and Director 2016-05-20Buy2,750$15.57-61.14view
Janssen RobertVice President 2016-05-12Buy1,000$15.12-59.99view
Janssen RobertVice President 2015-10-08Buy100$23.34-74.08view
Gray EddieCEO and Director 2014-08-14Buy2,500$14.9-59.4view
KISNER DANIEL LDirector 2013-10-30Buy1,000$10.8-43.98view
ORONSKY ARNOLD LDirector 2013-10-30Buy18,605$10.8-43.98view
Phillips Peggy VDirector 2013-10-30Buy9,302$10.8-43.98view
Janssen RobertChief Medical Officer and VP 2013-07-09Sell0$0-43.98view

Press Releases about DVAX :

Quarterly/Annual Reports about DVAX:

News about DVAX:

Articles On GuruFocus.com
Trump Victory Gives Life to Pharma,Biotech - Take a Look at VBI Vaccines Nov 11 2016 
Steven Cohen Increases Position in Dynavax Oct 07 2016 
VBI Vaccines: The Safer Alternative to the Struggling Dynavax Technologies Sep 06 2016 
William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
Two Promising Health Care Stocks with Market Capitalizations Under $500 Million Jun 11 2014 
Top Three Largest Insider Buys of the Past Week Nov 05 2013 
Steven Cohen, George Soros, John Paulson All Add to Holdings Mar 07 2012 
Dynavax Technologies Corp. Reports Operating Results (10-Q) Aug 02 2010 
Dynavax Technologies Corp. Reports Operating Results (10-Q) May 10 2010 
Price % Loser Stocks of The Day: SIGA Technologies Inc., Universal Travel Group, U.S. Concrete Inc., Dec 10 2009 

More From Other Websites
ETFs with exposure to Dynavax Technologies Corp. : March 27, 2017 Mar 27 2017
Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 23, 2017 Mar 23 2017
Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: 2016 By the Numbers : March 23, 2017 Mar 23 2017
Dynavax Announces Upcoming Data Presentations for Three TLR9 Agonist Programs at the 2017 American... Mar 20 2017
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 13 2017
DYNAVAX TECHNOLOGIES CORP Files SEC form 10-K, Annual Report Mar 13 2017
Dynavax Technologies reports 4Q loss Mar 13 2017
Dynavax Technologies reports 4Q loss Mar 13 2017
Dynavax Reports Fourth Quarter and Year End 2016 Financial Results and Company Update Mar 13 2017
[video]The 'Gnarly 9' Biotechs Will Test the FDA's Mettle Mar 08 2017
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle Mar 08 2017
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 06 2017
UPDATE: Dynavax shares reverse premarket losses to open flat Mar 06 2017
Dynavax Presents Promising Clinical Data from Lead Immuno-Oncology Candidate, SD-101, at the... Mar 06 2017
Biotech's Outlook Strengthens After President Trump's Speech: Today's Reports on Dynavax... Mar 02 2017
Dynavax to Present at the Cowen and Company 37th Annual Health Care Conference Mar 02 2017
Here’s What’s Next For Lexicon Pharmaceuticals, Inc. (LXRX) And Dynavax Technologies Corporation... Mar 01 2017
Dynavax stock surges 53% on new FDA review of Hep B vaccine and Trump statements about FDA... Mar 01 2017
4 Biopharma Stocks Moving the Market on Wednesday Mar 01 2017
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other... Feb 28 2017
Dynavax Restructures and Emphasizes Immuno-Oncology Program Jan 05 2017
Dynavax to Webcast Cancer R&D Day on December 9, 2016 Dec 01 2016
Dynavax to Present Clinical Data from Immuno-oncology Product Candidate, SD-101 Dec 01 2016
Dynavax Receives Complete Response Letter from U.S. Food and Drug Administration for Biologics... Nov 14 2016
Dynavax Presents Early Clinical Data from Lead Cancer Immunotherapy Candidate, SD-101, at Society... Nov 09 2016
Dynavax Reports Third Quarter 2016 Financial Results and Company Update Nov 07 2016
Dynavax Secures Committed Financing From Deerfield for $100 Million of Senior Secured Notes Oct 27 2016
Dynavax Presents Data Showing That HEPLISAV-B Provides Significantly Higher Seroprotection Rates... Oct 26 2016
Dynavax Provides Regulatory Update on HEPLISAV-B Sep 04 2016
Dynavax Reports Second Quarter 2016 Financial Results Aug 05 2016
Dynavax Announces FDA Advisory Committee Meeting to Review HEPLISAV-B Aug 05 2016
Dynavax Presents New Efficacy Data on Hepatitis B Vaccine, HEPLISAV-B(TM), in Adults With Type 2... Jun 11 2016
Dynavax to Present at Two Upcoming Investor Conferences May 18 2016
Dynavax Reports First Quarter 2016 Financial Results May 09 2016
Dynavax Receives Notification of PDUFA Extension for HEPLISAV-B to December 15, 2016 Apr 27 2016
Dynavax Presents Encouraging Data From Clinical Trial of Immuno-Oncology Product Candidate, SD-101 Apr 18 2016
Dynavax Presents Pivotal Phase 3 Data Showing HEPLISAV-B(TM) Provides Significantly Higher... Apr 18 2016
Dynavax to Present Data From Pivotal Phase 3 HEPLISAV-B(TM) Trial Apr 04 2016
Dynavax Announces FDA Acceptance for Review of Biologics License Application and PDUFA Action Date... Mar 30 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)